Laboratory Corp. of America Hldgs (LH)

Sector:Health Care
Super Investor Stats:
Ownership count:4
Ownership rank:100
% of all portfolios:0.252%
Hold Price * :$130.29
History Portfolio Manager Activity Share change % change to portfolio
Q2  2016
Wallace Weitz - Weitz Value Add 21.21% 35,000 0.65
Charles Bobrinskoy - Ariel Focus Add 5.63% 900 0.27
Q1  2016
Wallace Weitz - Weitz Value Add 81.32% 74,000 1.14
John Rogers - Ariel Appreciation Add 4.33% 24,700 0.17
Q4  2015
John Rogers - Ariel Appreciation Add 4.45% 24,300 0.17
Charles Bobrinskoy - Ariel Focus Reduce 2.44% 400 0.12
Richard Pzena - Hancock Classic Value Sell 100.00% 83,924 0.48
Q3  2015
John Rogers - Ariel Appreciation Add 10.54% 52,000 0.32
Charles Bobrinskoy - Ariel Focus Reduce 12.77% 2,400 0.60
Richard Pzena - Hancock Classic Value Reduce 59.98% 125,800 0.72
Christopher Davis - Clipper Sell 100.00% 232,940 2.74
Q2  2015
John Rogers - Ariel Appreciation Add 11.35% 50,300 0.31
Charles Bobrinskoy - Ariel Focus Reduce 5.05% 1,000 0.20
Wallace Weitz - Weitz Value Reduce 27.20% 34,000 0.46
Christopher Davis - Clipper Reduce 28.09% 91,000 1.07
Q1  2015
Richard Pzena - Hancock Classic Value Reduce 17.10% 43,275 0.22
Q4  2014
Charles Bobrinskoy - Ariel Focus Reduce 3.41% 700 0.11
Richard Pzena - Hancock Classic Value Reduce 54.74% 305,950 1.26
Thomas Gayner - Markel Asset Management Sell 100.00% 15,000 0.04
Q3  2014
Richard Pzena - Hancock Classic Value Reduce 11.93% 75,750 0.27
Q2  2014
John Rogers - Ariel Appreciation Add 10.88% 43,500 0.22
Thomas Gayner - Markel Asset Management Buy 15,000 0.04
Christopher Davis - Clipper Reduce 32.95% 159,200 1.37
Q1  2014
Christopher Davis - Clipper Add 16.88% 69,760 0.58
Wallace Weitz - Weitz Value Add 13.64% 15,000 0.18
Charles Bobrinskoy - Ariel Focus Buy 20,500 3.32
John Rogers - Ariel Appreciation Buy 399,700 1.98
Richard Pzena - Hancock Classic Value Reduce 3.29% 21,576 0.08
Q4  2013
Christopher Davis - Clipper Add 35.69% 108,740 0.82
Richard Pzena - Hancock Classic Value Add 11.87% 69,650 0.23

* "Hold Price" is the term we use to indicate the price at which our Super Investors are comfortable owning a security. It is the price of the security as of the portfolio date (usually quarter end). It's a reasonable indicator of a stock's undervaluation at that price, otherwise it would have been sold. We only provide this value when a security is owned by at least two Super Investors. In the case of reporting dates being different, we calculate a weighted average price.